Global Botanical Drug Competitive Landscape Professional Research Report 2025
Description
Global Botanical Drug Competitive Landscape Professional Research Report 2025
Research Summary
A botanical drug, also known as a phytomedicine or a phytopharmaceutical, refers to a drug or medicinal product that is derived from botanical sources, primarily plants or plant extracts. These drugs are developed and formulated using active ingredients obtained from plants, which may include leaves, flowers, stems, roots, or other plant parts. Botanical drugs have been used for centuries in traditional medicine systems, such as Ayurveda, Traditional Chinese Medicine (TCM), and Native American medicine. In recent years, there has been growing interest in the development of botanical drugs within the framework of modern medicine. To be classified as a botanical drug, a product must meet certain criteria and undergo a regulatory approval process. The specific requirements vary depending on the country or regulatory agency involved. In the United States, for example, the U.S. Food and Drug Administration (FDA) has established guidelines for the development, evaluation, and approval of botanical drugs under the category of botanical drug products (BDPs). Botanical drugs can be developed as single-ingredient formulations or as complex mixtures of various plant constituents. They may be used to treat a wide range of conditions, including but not limited to cardiovascular disorders, respiratory diseases, immune disorders, gastrointestinal issues, and skin conditions. It＇s important to note that while botanical drugs are derived from natural sources, they still undergo rigorous scientific and clinical evaluation to ensure safety, efficacy, and quality. This involves conducting preclinical studies, clinical trials, and adhering to good manufacturing practices to produce standardized and consistent products.
According to DIResearch's in-depth investigation and research, the global Botanical Drug market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Botanical Drug include Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Jumpcan Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, Yunnan Baiyao, Tasly Holding Group, Bionorica Se, Weleda, Taiji, Huarun 999, Kwangdong, GW Pharmaceuticals etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Botanical Drug. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Botanical Drug market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Botanical Drug market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Botanical Drug industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Botanical Drug Include:
Buchang Pharmaceuticals
China TCM
Tsumura
Schwabe
Tong Ren Tang
Jumpcan Pharmaceutical
Guangzhou Baiyunshan Pharmaceutical
Yunnan Baiyao
Tasly Holding Group
Bionorica Se
Weleda
Taiji
Huarun 999
Kwangdong
GW Pharmaceuticals
Botanical Drug Product Segment Include:
Prescription Drug
OTC Drug
Botanical Drug Product Application Include:
Cardiovascular
Tumor
Respiratory System
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Botanical Drug Industry PESTEL Analysis
Chapter 3: Global Botanical Drug Industry Porter’s Five Forces Analysis
Chapter 4: Global Botanical Drug Major Regional Market Size and Forecast Analysis
Chapter 5: Global Botanical Drug Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Botanical Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Botanical Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Botanical Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Botanical Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Botanical Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Botanical Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Botanical Drug Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Botanical Drug Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Botanical Drug Product by Type
- 1.2.1 Prescription Drug
- 1.2.2 OTC Drug
- 1.3 Botanical Drug Product by Application
- 1.3.1 Cardiovascular
- 1.3.2 Tumor
- 1.3.3 Respiratory System
- 1.3.4 Others
- 1.4 Global Botanical Drug Market Size Analysis (2020-2032)
- 1.5 Botanical Drug Market Development Status and Trends
- 1.5.1 Botanical Drug Industry Development Status Analysis
- 1.5.2 Botanical Drug Industry Development Trends Analysis
- 2 Botanical Drug Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Botanical Drug Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Botanical Drug Market Analysis by Regions
- 4.1 Botanical Drug Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Botanical Drug Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Botanical Drug Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Botanical Drug Revenue Forecast by Region (2026-2032)
- 5 Global Botanical Drug Market Size by Type and Application
- 5.1 Global Botanical Drug Market Size by Type (2020-2032)
- 5.2 Global Botanical Drug Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Botanical Drug Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Botanical Drug Market Size by Type
- 6.4 North America Botanical Drug Market Size by Application
- 6.5 North America Botanical Drug Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Botanical Drug Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Botanical Drug Market Size by Type
- 7.4 Europe Botanical Drug Market Size by Application
- 7.5 Europe Botanical Drug Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Botanical Drug Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Botanical Drug Market Size by Type
- 8.4 China Botanical Drug Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Botanical Drug Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Botanical Drug Market Size by Type
- 9.4 APAC (excl. China) Botanical Drug Market Size by Application
- 9.5 APAC (excl. China) Botanical Drug Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Botanical Drug Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Botanical Drug Market Size by Type
- 10.4 Latin America Botanical Drug Market Size by Application
- 10.5 Latin America Botanical Drug Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Botanical Drug Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Botanical Drug Market Size by Type
- 11.4 Middle East & Africa Botanical Drug Market Size by Application
- 11.5 Middle East & Africa Botanical Drug Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Botanical Drug Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Botanical Drug Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Botanical Drug Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Buchang Pharmaceuticals
- 13.1.1 Buchang Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Buchang Pharmaceuticals Botanical Drug Product Portfolio
- 13.1.3 Buchang Pharmaceuticals Botanical Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 China TCM
- 13.2.1 China TCM Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 China TCM Botanical Drug Product Portfolio
- 13.2.3 China TCM Botanical Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Tsumura
- 13.3.1 Tsumura Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Tsumura Botanical Drug Product Portfolio
- 13.3.3 Tsumura Botanical Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 Schwabe
- 13.4.1 Schwabe Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Schwabe Botanical Drug Product Portfolio
- 13.4.3 Schwabe Botanical Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Tong Ren Tang
- 13.5.1 Tong Ren Tang Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Tong Ren Tang Botanical Drug Product Portfolio
- 13.5.3 Tong Ren Tang Botanical Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 Jumpcan Pharmaceutical
- 13.6.1 Jumpcan Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Jumpcan Pharmaceutical Botanical Drug Product Portfolio
- 13.6.3 Jumpcan Pharmaceutical Botanical Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 Guangzhou Baiyunshan Pharmaceutical
- 13.7.1 Guangzhou Baiyunshan Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Product Portfolio
- 13.7.3 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 Yunnan Baiyao
- 13.8.1 Yunnan Baiyao Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Yunnan Baiyao Botanical Drug Product Portfolio
- 13.8.3 Yunnan Baiyao Botanical Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 Tasly Holding Group
- 13.9.1 Tasly Holding Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Tasly Holding Group Botanical Drug Product Portfolio
- 13.9.3 Tasly Holding Group Botanical Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 Bionorica Se
- 13.10.1 Bionorica Se Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Bionorica Se Botanical Drug Product Portfolio
- 13.10.3 Bionorica Se Botanical Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.11 Weleda
- 13.11.1 Weleda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Weleda Botanical Drug Product Portfolio
- 13.11.3 Weleda Botanical Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.12 Taiji
- 13.12.1 Taiji Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 Taiji Botanical Drug Product Portfolio
- 13.12.3 Taiji Botanical Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.13 Huarun 999
- 13.13.1 Huarun 999 Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 Huarun 999 Botanical Drug Product Portfolio
- 13.13.3 Huarun 999 Botanical Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.14 Kwangdong
- 13.14.1 Kwangdong Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.14.2 Kwangdong Botanical Drug Product Portfolio
- 13.14.3 Kwangdong Botanical Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.15 GW Pharmaceuticals
- 13.15.1 GW Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.15.2 GW Pharmaceuticals Botanical Drug Product Portfolio
- 13.15.3 GW Pharmaceuticals Botanical Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Botanical Drug Industry Chain Analysis
- 14.2 Botanical Drug Industry Raw Material and Suppliers Analysis
- 14.2.1 Botanical Drug Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Botanical Drug Typical Downstream Customers
- 14.4 Botanical Drug Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
